XML 65 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION (Details) (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
STOCK-BASED COMPENSATION    
Proceeds from stock option exercises $ 38,368,000 $ 35,239,000
Stock options
   
STOCK-BASED COMPENSATION    
Award vesting period 3 years  
Expiration period 10 years  
Compensation expense 11,500,000 10,800,000
Compensation expense, net of tax 7,700,000 7,200,000
Income tax benefit related to compensation expense 3,800,000 3,600,000
Weighted-average fair value of stock options granted (in dollars per share) $ 10.16 $ 10.35
Grant date fair value of options vested 12,900,000 12,100,000
Proceeds from stock option exercises 38,400,000  
Tax benefit realized for the tax deduction from option exercises 7,900,000  
Unrecognized compensation cost expected to be recognized in future periods 12,000,000  
Weighted-average period over which compensation cost is expected to be recognized 1 year 6 months  
Stock options | Selling, research & development and administrative expenses
   
STOCK-BASED COMPENSATION    
Compensation expense, net of tax 10,200,000 9,600,000
Stock Awards Plans | Stock options
   
Assumptions used to estimate fair value of stock options granted    
Dividend Yield (as a percent) 1.80% 1.80%
Expected Stock Price Volatility (as a percent) 22.70% 22.90%
Risk-free Interest Rate (as a percent) 1.30% 1.30%
Expected Life of Option 6 years 10 months 24 days 6 years 10 months 24 days
Stock options activity    
Outstanding at the beginning of the period (in shares) 7,879,197  
Granted (in shares) 1,385,300  
Exercised (in shares) (1,249,180)  
Forfeited or expired (in shares) (47,399)  
Outstanding at the end of the period (in shares) 7,967,918  
Exercisable at the end of the period (in shares) 5,396,418  
Weighted Average Exercise Price    
Outstanding at the beginning of the period (in dollars per share) $ 37.27  
Granted (in dollars per share) $ 51.83  
Exercised (in dollars per share) $ 28.60  
Forfeited or expired (in dollars per share) $ 47.24  
Outstanding at the end of the period (in dollars per share) $ 41.10  
Exercisable at the end of the period (in dollars per share) $ 36.26  
Weighted-Average Remaining Contractual Term (Years):    
Outstanding at the end of the period 6 years 3 months 18 days  
Exercisable at the end of the period 5 years 1 month 6 days  
Aggregate Intrinsic Value:    
Outstanding at the end of the period 151,630,000  
Exercisable at the end of the period 128,807,000  
Intrinsic Value of Options Exercised 33,123,000 34,674,000
Stock Awards Plans | Restricted stock units
   
STOCK-BASED COMPENSATION    
Award vesting period 3 years  
Compensation expense, net of tax 574,000 438,000
Unrecognized compensation cost expected to be recognized in future periods 611,000  
Weighted-average period over which compensation cost is expected to be recognized 1 year 6 months  
Restricted stock unit activity    
Balance at the beginning of the period (in shares) 25,862  
Granted (in shares) 12,448  
Vested (in shares) (12,629)  
Balance at the end of the period (in shares) 25,681  
Weighted-Average Grant-Date Fair Value    
Nonvested at the beginning of the period (in dollars per share) $ 48.76  
Granted (in dollars per share) $ 54.92  
Vested (in dollars per share) $ 45.20  
Nonvested at the end of the period (in dollars per share) $ 53.49  
Fair value of units vested 571,000 316,000
Intrinsic value of units vested 661,000 448,000
Director Stock Option Plans | Stock options
   
STOCK-BASED COMPENSATION    
Weighted-average fair value of stock options granted (in dollars per share) $ 10.89 $ 10.59
Assumptions used to estimate fair value of stock options granted    
Dividend Yield (as a percent) 1.90% 1.70%
Expected Stock Price Volatility (as a percent) 23.00% 22.50%
Risk-free Interest Rate (as a percent) 1.30% 1.30%
Expected Life of Option 6 years 10 months 24 days 6 years 10 months 24 days
Stock options activity    
Outstanding at the beginning of the period (in shares) 276,667  
Granted (in shares) 85,500  
Exercised (in shares) (48,333)  
Outstanding at the end of the period (in shares) 313,834  
Exercisable at the end of the period (in shares) 146,001  
Weighted Average Exercise Price    
Outstanding at the beginning of the period (in dollars per share) $ 45.48  
Granted (in dollars per share) $ 56.49  
Exercised (in dollars per share) $ 43.11  
Outstanding at the end of the period (in dollars per share) $ 48.85  
Exercisable at the end of the period (in dollars per share) $ 42.05  
Weighted-Average Remaining Contractual Term (Years):    
Outstanding at the end of the period 7 years 9 months 18 days  
Exercisable at the end of the period 6 years 4 months 24 days  
Aggregate Intrinsic Value:    
Outstanding at the end of the period 3,541,000  
Exercisable at the end of the period 2,640,000  
Intrinsic Value of Options Exercised $ 732,000 $ 937,000